Clinical Trials Browser

Phase 4 × Withdrawn × Lymphoma, Large-Cell, Anaplastic × Clear all

NCT02487316 2016-12-30

A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib

Phase 4 Withdrawn

Lymphoma, Large-Cell, Anaplastic